Laurie Lisak

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes

Azra Raza, Peter Meyer, Diya Dutt et al. · Blood · 2001 · 303 citations · Full text

The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes

Francesca Zorat, Vilasini Shetty, Diya Dutt et al. · British Journal of Haematology · 2001 · 106 citations · Full text

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression

Azra Raza, Silvia Buonamici, Laurie Lisak et al. · Leukemia Research · 2004 · 78 citations · Full text

Hematological Malignancy, Bone Marrow Failure, Myelodysplastic Syndromes Patients +8

Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone

Azra Raza, Huma Qawi, Laurie Lisak et al. · Blood · 2000 · 73 citations

Remicade as TNF Suppressor in Patients with Myelodysplastic Syndromes

Azra Raza, Anna Candoni, Uzair Ali Khan et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2004 · 54 citations · Full text

Hematological Malignancy, Thrombosis, Translational Medicine +15